
Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors
Keywords: PDE10A; Schizophrenia; Cinnolines; Phosphodiesterase; Metabolism